Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9464144 [patent_doc_number] => 20140128571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS' [patent_app_type] => utility [patent_app_number] => 14/147990 [patent_app_country] => US [patent_app_date] => 2014-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47088 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147990 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/147990
AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS Jan 5, 2014 Abandoned
Array ( [id] => 9561954 [patent_doc_number] => 20140179667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'ARYL AND HETEROARYL FUSED LACTAMS' [patent_app_type] => utility [patent_app_number] => 14/132567 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 104955 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132567 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/132567
Aryl and heteroaryl fused lactams Dec 17, 2013 Issued
Array ( [id] => 10540652 [patent_doc_number] => 09265754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-23 [patent_title] => 'Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome' [patent_app_type] => utility [patent_app_number] => 14/097623 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 6794 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14097623 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/097623
Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome Dec 4, 2013 Issued
Array ( [id] => 10405224 [patent_doc_number] => 20150290233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/432520 [patent_app_country] => US [patent_app_date] => 2013-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28123 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432520 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/432520
METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS Nov 27, 2013 Abandoned
Array ( [id] => 9384641 [patent_doc_number] => 20140088123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'TREATMENT OF LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 14/091861 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9687 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091861 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/091861
TREATMENT OF LUNG CANCER Nov 26, 2013 Abandoned
Array ( [id] => 9538343 [patent_doc_number] => 20140162991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'TESTOSTERONE-ANASTROZOLE (T + A) COMBINATION IMPLANTS IN THE NEO-ADJUVANT, LOCAL AND SYSTEMIC THERAPY OF NEWLY DIAGNOSED, PREVIOUSLY UNTREATED BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 14/090443 [patent_app_country] => US [patent_app_date] => 2013-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4494 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090443 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/090443
TESTOSTERONE-ANASTROZOLE (T + A) COMBINATION IMPLANTS IN THE NEO-ADJUVANT, LOCAL AND SYSTEMIC THERAPY OF NEWLY DIAGNOSED, PREVIOUSLY UNTREATED BREAST CANCER Nov 25, 2013 Abandoned
Array ( [id] => 9944272 [patent_doc_number] => 08993573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => '2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors' [patent_app_type] => utility [patent_app_number] => 14/089946 [patent_app_country] => US [patent_app_date] => 2013-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 21628 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089946 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/089946
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Nov 25, 2013 Issued
Array ( [id] => 11857882 [patent_doc_number] => 09737549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Formulations of deoxycholic acid and salts thereof' [patent_app_type] => utility [patent_app_number] => 14/091109 [patent_app_country] => US [patent_app_date] => 2013-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091109 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/091109
Formulations of deoxycholic acid and salts thereof Nov 25, 2013 Issued
Array ( [id] => 9511950 [patent_doc_number] => 20140148443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'Novel Imidazolines as dual inhibitors of MDM2 and MDMX' [patent_app_type] => utility [patent_app_number] => 14/084681 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18924 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084681 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/084681
Novel Imidazolines as dual inhibitors of MDM2 and MDMX Nov 19, 2013 Abandoned
Array ( [id] => 9370915 [patent_doc_number] => 20140080789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'Method of Treating Diabetes, Glucose Intolerance, Insulin Resistance and/or Diabetes-Induced Diastolic Dysfunction' [patent_app_type] => utility [patent_app_number] => 14/083841 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083841 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/083841
Method of Treating Diabetes, Glucose Intolerance, Insulin Resistance and/or Diabetes-Induced Diastolic Dysfunction Nov 18, 2013 Abandoned
Array ( [id] => 11828744 [patent_doc_number] => 09725477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino' [patent_app_type] => utility [patent_app_number] => 14/762145 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30621 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762145 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/762145
Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino Nov 14, 2013 Issued
Array ( [id] => 10387916 [patent_doc_number] => 20150272922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof' [patent_app_type] => utility [patent_app_number] => 14/441620 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25200 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441620 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/441620
Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof Nov 7, 2013 Abandoned
Array ( [id] => 9363705 [patent_doc_number] => 20140073579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'SMAC Mimetic' [patent_app_type] => utility [patent_app_number] => 14/075190 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18501 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075190 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/075190
SMAC mimetic for treating myelodysplastic syndromes Nov 7, 2013 Issued
Array ( [id] => 9363762 [patent_doc_number] => 20140073635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'Substituted Imidazopyridinyl-Aminopyridine Compounds' [patent_app_type] => utility [patent_app_number] => 14/075505 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57508 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075505 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/075505
Substituted imidazopyridinyl-aminopyridine compounds Nov 7, 2013 Issued
Array ( [id] => 11783943 [patent_doc_number] => 09393216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Vaginal matrices: nanofibers for contraception and prevention of HIV infection' [patent_app_type] => utility [patent_app_number] => 14/073734 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 39 [patent_no_of_words] => 36788 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073734 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/073734
Vaginal matrices: nanofibers for contraception and prevention of HIV infection Nov 5, 2013 Issued
Array ( [id] => 9338464 [patent_doc_number] => 20140065246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'INTRACELLULAR CALCIUM MODULATION FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/073850 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7510 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073850 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/073850
INTRACELLULAR CALCIUM MODULATION FOR CANCER TREATMENT Nov 5, 2013 Abandoned
Array ( [id] => 9462758 [patent_doc_number] => 20140127185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 14/068475 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12213 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068475 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/068475
METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS Oct 30, 2013 Abandoned
Array ( [id] => 9331115 [patent_doc_number] => 20140057897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS' [patent_app_type] => utility [patent_app_number] => 14/068017 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1371 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068017 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/068017
METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS Oct 30, 2013 Abandoned
Array ( [id] => 10114661 [patent_doc_number] => 09149525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Delivery of corticosteroids through iontophoresis' [patent_app_type] => utility [patent_app_number] => 14/060055 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9328 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060055 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/060055
Delivery of corticosteroids through iontophoresis Oct 21, 2013 Issued
Array ( [id] => 9422439 [patent_doc_number] => 20140107090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'TREATMENT AND PREVENTION OF MASTITIS' [patent_app_type] => utility [patent_app_number] => 14/056122 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20110 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056122 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/056122
Treatment and prevention of mastitis Oct 16, 2013 Issued
Menu